LONDON and NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic ...
(RTTNews) - OKYO Pharma Limited (OKYO) has announced that its lead drug candidate, OK-101, has officially been assigned the United States Adopted Name or USAN "Urcosimod." This name reflects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback